Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionization

Journal of Mass Spectrometry

Volumn 42, Issue 2, 2007, Pages 150-160

  Beyer, Jochen ^a   Peters, Frank T ^a   Kraemer, Thomas ^a   Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Herbal stimulants; LC MS MS; Methcathinone; Phenalkylamines; Plasma

Indexed keywords

ELECTROSPRAY IONIZATION; HERBAL STIMULANTS; METHCATHINONE; PHENALKYLAMINES;

DRUG PRODUCTS; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; PLANTS (BOTANY); PLASMAS;

BLOOD;

CATHA EDULIS EXTRACT; CATHINONE; EPHEDRA EXTRACT; EPHEDRINE; MESCALINE; METHCATHINONE; METHYLEPHEDRINE; METHYLPSEUDOEPHEDRINE; NOREPHEDRINE; NORPSEUDOEPHEDRINE; PHENYLALKYLAMINE; PSEUDOEPHEDRINE; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CATHA EDULIS; CONTROLLED STUDY; DRUG ABUSE; ELECTROSPRAY; EPHEDRA; HUMAN; INTERNET; LIQUID CHROMATOGRAPHY; LOPHOPHORINE; MASS SPECTROMETRY; MEDICINAL PLANT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPHEDRINE; HUMANS; PLANT EXTRACTS; PROPIOPHENONES; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION;

CATHA EDULIS; EPHEDRA; LOPHOPHORA WILLIAMSII;

EID: 33847014591     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1132     Document Type: Article

References (43)

1. Raetsch C. Enzyklopädie der Psychoaktiven Pflanzen. Wissenschaftliche Verlagsgesellschaft: Stuttgart, 1998; 261.
2. Nencini P. Cathinone, active principle of the khat leaf: its effects on in vivo and in vitro lipolysis. Pharmacol. Res. Commun. 1980; 12: 855.
3. El Seedi HR, Smet PA, Beck O, Possnert G, Bruhn JG. Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. J. Ethnopharmacol. 2005; 101: 238.
4. Kovar KA. Chemistry and pharmacology of hallucinogens, entactogens and stimulants. Pharmacopsychiatry 1998; 31: 69.
5. Kalix P. The pharmacology of psychoactive alkaloids from ephedra and catha. J. Ethnopharmacol. 1991; 32: 201.
6. Li HX, Ding MY, Lv K, Yu JY. Separation and determination of ephedrine alkaloids and tetramethylpyrazine in Ephedra sinica Stapf by gas chromatography-mass spectrometry. J. Chromatogr. Sci. 2001; 39: 370.
7. Sullivan D, Wehrmann J, Schmitz J, Crowley R, Eberhard J. Determination of ephedra alkaloids by liquid chromatography/tandem mass spectrometry. J. AOAC Int. 2003; 86: 471.
8. Wang M, Marriott PJ, Chan WH, Lee AW, Huie CW. Enantiomeric separation and quantification of ephedrine-type alkaloids in herbal materials by comprehensive two-dimensional gas chromatography. J. Chromatogr., A 2006; 1112: 361.
9. Toennes SW, Kauert GF. Excretion and detection of cathinone, cathine, and phenylpropanolamine in urine after kath chewing. Clin. Chem. 2002; 48: 1715.
10. Widler P, Mathys K, Brenneisen R, Kalix P, Fisch HU. Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin. Pharmacol. Ther. 1994; 55: 556.
11. Belhadj-Tahar H, Sadeg N. Methcathinone: a new postindustrial drug. Forensic Sci. Int. 2005; 153: 99.
12. Emerson TS, Cisek JE. Methcathinone: a Russian designer amphetamine infiltrates the rural midwest [published erratum appears in Ann Emerg Med 1994 Apr;23(4):790]. Ann. Emerg. Med. 1993; 22: 1897.
13. Glennon RA, Yousif M, Naiman N, Kalix P. Methcathinone: a new and potent amphetamine-like agent. Pharmacol., Biochem. Behav. 1987; 26: 547.
14. Glennon RA, Young R, Martin BR, Dal-Cason TA. Methcathione ("cat"): an enantiomeric potency comparison. Pharmacol., Biochem. Behav. 1995; 50: 601.
15. Gygi MP, Gibb JW, Hanson GR. Methcathinone: an initial study of its effects on monoaminergic systems. J. Pharmacol. Exp. Ther. 1996; 276: 1066.
16. Sparago M, Wlos J, Yuan J, Hatzidimitriou G, Tolliver J, Dal-Cason TA, Katz J, Ricaurte G. Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse. J. Pharmacol. Exp. Ther. 1996; 279: 1043.
17. Young R, Glennon RA. Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse. Psychopharmacology (Berlin) 1998; 140: 250.
18. Gay ML, Niemann RA, Musser SM. An isotopically labeled internal standard liquid chromatography-tandem mass spectrometry method for determination of ephedrine alkaloids and synephrine in dietary supplements. J. Agric. Food Chem. 2006; 54: 285.
19. Niemann RA, Gay ML. Determination of ephedrine alkaloids and synephrine in dietary supplements by column-switching cation exchange high-performance liquid chromatography with scanning-wavelength ultraviolet and fluorescence detection. J. Agric. Food Chem. 2003; 51: 5630.
20. Maurer HH. Demands on scientific studies in clinical toxicology. Forensic Sci. Int. 2006; [Epub ahead of print].
21. Binder SR, Adams AK, Regalia M, Essien H, Rosenblum R. Standardization of a multi-wavelength UV detector for liquid chromatography-based toxicological analysis. J. Chromatogr. 1991; 550: 449.
22. Chan KH, Pan RN, Hsu MC. Simultaneous quantification of six ephedrines in a Mahwang preparation and in urine by high-performance liquid chromatography. Biomed. Chromatogr. 2005; 19: 337.
23. Nieder M, Jaeger H. Sensitive quantification of pseudoephedrine in human plasma and urine by high-performance liquid chromatography. J. Chromatogr. 1988; 424: 73.
24. Roman MC. Determination of ephedra alkaloids in urine and plasma by HPLC-UV: collaborative study. J. AOAC Int. 2004; 87: 15.
25. Bogusz MJ, Kruger KD, Maier RD. Analysis of underivatized amphetamines and related phenethylamlnes with high-performance liquid chromatography- atmospheric pressure chemical ionization mass spectrometry. J. Anal. Toxicol. 2000; 24: 77.
26. Sun J, Wang G, Wang W, Zhao S, Gu Y, Zhang J, Huang M, Shao F, Li H, Zhang Q, Xie H. Simultaneous determination of loratadine and pseudoephedrine sulfate in human plasma by liquid chromatography-electrospray mass spectrometry for pharmacokinetic studies. J. Pharm. Biomed. Anal. 2005; 39: 217.
27. Chen X, Zhang Y, Zhong D. Simultaneous determination of chlorpheniramine and pseudoephedrine in human plasma by liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 2004; 18: 248.
28. Trujillo WA, Sorenson WR. Determination of ephedrine alkaloids in human urine and plasma by liquid chromatography/tandem mass spectrometry: collaborative study. J. AOAC Int. 2003; 86: 643.
29. Zhu L, Chen X, Zhang Y, Yu H, Zhong D. Simultaneous determination of methylephedrine and noscapine in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005; 820: 175.
30. Habrdova V, Peters FT, Theobald DS, Maurer HH. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry. J. Mass Spectrom. 2005; 40: 785.
31. Helmlin HJ, Brenneisen R. Determination of psychotropic phenylalkylamine derivatives in biological matrices by high-performance liquid chromatography with photodiode-array detection. J. Chromatogr. 1992; 593: 87.
32. Henry JL, Epley J, Rohrig TP. The analysis and distribution of mescaline in postmortem tissues. J. Anal. Toxicol. 2003; 27: 381.
33. Mathys K, Brenneisen R. Determination of (S)-(-)-cathinone and its metabolites (R,S)-(-)-norephedrine and (R,R)-(-)-norpseudoephedrine in urine by high-performance liquid chromatography with photodiode-array detection. J. Chromatogr. 1992; 593: 79.
34. Massart DL, Vandeginste BGM, Buydens LMC, De Jong S, Lewi PJ, Smeyers-Verbeke J. Handbook of Chemometrics and Qualimetrics: Part A, Vandeginste BGM, Rutan SC (eds). Elsevier: Amsterdam, 1997; 379.
35. Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J. Mass Spectrom. 2003; 38: 659.
36. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. Bioanalytical method validation - a revisit with a decade of progress. Pharm. Res. 2000; 17: 1551.
37. Peters FT, Maurer HH. Bioanalytical method validation and its implications for forensic and clinical toxicology - A review [review]. Accred. Qual. Assur. 2002; 7: 441.
38. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003; 75: 3019.
39. Peters FT. Applications of Liquid Chromatography-mass Spectrometry in Toxicology, Polettini A (ed.). Pharmaceutical Press: London, 2006; 71.
40. U.S.Department of Health and Human Services FaDA. Guidance for Industry, Bioanalytical Method Validation, http://www. fda.gov/cder/guidance/index.htm, 2001.
41. Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic Sci. Int. 2006; [Epub ahead of print].
42. Maurer HH, Tenberken O, Kratzsch C, Weber AA, Peters FT. Screening for, library-assisted identification and fully validated quantification of twenty-two beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization. J. Chromatogr., A 2004; 1058: 169.
43. Kratzsch C, Weber AA, Peters FT, Kraemer T, Maurer HH. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. J. Mass Spectrom. 2003; 38: 283.